| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Johnson & Johnson (JNJ) has 22 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. JNJ is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.04M | $933.52M | - | |
| VP | 193.5K | $44.71M | - | |
| VP | 46.2K | $10.68M | - | |
| VP | 34.7K | $8.01M | - | |
| CEO | 30.9K | $7.13M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2018 | Sneed Michael E | EVP, Global Corp Aff &COO | Sale+OE | 29,000 | $134.80 | $3,909,084.00 | -49.0% | |
| Feb 15, 2018 | Stoffels Paulus | Exec VP, Chief Scientific Off | Sale+OE | 155,342 | $129.86 | $20,172,401.44 | -43.4% | |
| Nov 20, 2017 | Johnson & Johnson59 | 10% Owner | Sell | 18,367,346 | $2.75 | $50,510,201.50 | -100% | |
| Jul 24, 2017 | Stoffels Paulus | Exec VP, Chief Scientific Off | Sale+OE | 102,692 | $133.14 | $13,672,628.53 | -44.6% | |
| Jul 20, 2017 | Caruso Dominic J | Exec VP, Finance; CFO | Sale+OE | 82,591 | $136.72 | $11,291,478.12 | -36.4% | |
| Mar 3, 2017 | Duato Joaquin | Exec VP, Ww Chair, Pharma | Sale+OE | 50,000 | $123.62 | $6,181,140.00 | -42.2% | |
| Feb 28, 2017 | Kapusta Ronald A | Controller, CAO | Sale+OE | 14,543 | $122.26 | $1,777,954.46 | -32.7% | |
| Feb 28, 2017 | Pruden Gary J | Exec VP, Ww Chair, Med Devices | Sell | 16,299 | $122.21 | $1,991,943.17 | -27.2% | |
| Feb 15, 2017 | Stoffels Paulus | Exec VP, Chief Scientific Off | Sell | 22,000 | $117.29 | $2,580,274.40 | -14.7% | |
| Feb 1, 2017 | Ullmann Michael H | Exec VP, General Counsel | Sale+OE | 21,735 | $112.88 | $2,453,442.45 | -18.2% |